GSK China Launches Programme to Train 7,000 Doctors
28 December 2015
Three-year partnership with National Health and Family Planning Commission underlines GSK’s commitment to medical education in China
Beijing, 26 December, 2015—Today, GSK China announced the launch of an independent training programme to enhance the capabilities of seven thousand Chinese doctors in the diagnosis and treatment of Hepatitis B.
The programme will run for three years and be delivered by the Development Centre for Medical Science and Technology under the National Health and Family Planning Commission of the People’s Republic of China.? The training programme will equip doctors with the skills to diagnose, treat and provide ongoing management to patients across China.? GSK will invest ?2 million (RMB 20 million) to support the programme over the three year period. The programme was announced on 22 October 2015 during President Xi Jinping’s visit to UK.
Sir Andrew Witty, Chief Executive Officer of GSK, noted in October that “Enabling medical education in China is an important part of our commitment to supporting grass roots professionals to improve their diagnosis and treatment of patients. This is one example of how GSK is seeking to support the reforms of the Chinese government and in doing so help improve the health of Chinese people.”
Mr Hervé Gisserot, SVP & GM, Pharmaceuticals and Vaccines, China/Hong Kong, said, “The support of this programme reaffirms GSK’s long-term commitment to serving China and the healthcare needs of patients in the country. Hepatitis B has been identified as a healthcare priority in China, with approximately 20 million sufferers across the country remaining untreated.”? Today’s launch follows a similar commitment made in September to provide independent training to Chinese doctors in respiratory condition, chronic obstructive pulmonary disease (COPD).
GSK has committed ?6 million (RMB 60 million) for public health initiatives in China over the next five years with around ?4 million (RMB 40 million) being spent on independent training for General Practitioners.?